Biofrontera (BFRI) Stock Forecast for 2023 – 2026. Sell or Buy?
Updated: December 6, 2023 (09:49)
Sector: HealthcareThe share price of Biofrontera Inc. (BFRI) now
50/200 Day Moving Average: $5.71 / $9.72
This figure corresponds to the Average Price over the previous 50/200 days. For Biofrontera stocks, the 50-day moving average is the resistance level today.
For Biofrontera stocks, the 200-day moving average is the resistance level today.
Are you interested in Biofrontera Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Biofrontera stock price in 2023, 2024, 2025, 2026, 2027. How much will one Biofrontera share be worth in 2023 - 2027?
When should I take profit in Biofrontera stock? When should I record a loss on Biofrontera stock? What are analysts' forecasts for Biofrontera stock? What is the future of Biofrontera stock? We forecast Biofrontera stock performance using neural networks based on historical data on Biofrontera stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Biofrontera stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Biofrontera shares. This happens once a day.
Historical and forecast chart of Biofrontera stock
The chart below shows the historical price of Biofrontera stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Biofrontera stock price can be found in the table below.
Long-term forecasts by years.
Biofrontera AG is a German biopharmaceutical company. The company develops medicines and medicinal cosmetics for the treatment of skin diseases and regenerative care for damaged skin. His portfolio includes: Ameluz, a photodynamic therapy (PDT) for actinic keratoses in development for other types of skin cancer and warts; BF-RhodoLED PDT lamp, used after treatment with Ameluz to eliminate infected cells; and Belixos, a dermatological cream with herbal ingredients for the care of itchy, inflamed and flaky skin and conditions such as insect bites, burns, neurodermatitis and psoriasis. The company is also in the clinical development of two candidate drugs: BF-derm1, a tablet with an inhibitor that blocks the synthesis of histamine in cells, which causes allergic reactions, and BF1, a selective serotonin receptor for the prevention of migraine. The company operates five wholly owned subsidiaries, notably Biofrontera Inc in the United States. Its main shareholder is MMF.
Biofrontera daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec 08 | 4.11 | 3.96 | 4.27 | 7.77 |
| Dec 09 | 4.04 | 3.91 | 4.22 | 7.95 |
| Dec 10 | 3.80 | 3.73 | 3.95 | 5.99 |
| Dec 11 | 3.69 | 3.50 | 3.78 | 8.19 |
| Dec 12 | 3.86 | 3.73 | 3.95 | 5.65 |
| Dec 13 | 3.81 | 3.63 | 3.93 | 8.15 |
| Dec 14 | 3.93 | 3.83 | 4.13 | 7.67 |
| Dec 15 | 3.94 | 3.72 | 4.05 | 8.80 |
| Dec 16 | 4.11 | 4.00 | 4.31 | 7.84 |
| Dec 17 | 3.82 | 3.72 | 3.95 | 6.04 |
| Dec 18 | 3.92 | 3.86 | 4.04 | 4.84 |
| Dec 19 | 4.06 | 3.85 | 4.18 | 8.56 |
| Dec 20 | 4.11 | 4.01 | 4.17 | 3.95 |
| Dec 21 | 4.23 | 4.16 | 4.31 | 3.63 |
| Dec 22 | 4.48 | 4.39 | 4.55 | 3.49 |
| Dec 23 | 4.61 | 4.50 | 4.78 | 6.02 |
| Dec 24 | 4.63 | 4.47 | 4.88 | 9.28 |
| Dec 25 | 4.64 | 4.41 | 4.88 | 10.61 |
| Dec 26 | 4.56 | 4.30 | 4.76 | 10.75 |
| Dec 27 | 4.51 | 4.28 | 4.74 | 10.85 |
| Dec 28 | 4.67 | 4.54 | 4.85 | 6.68 |
| Dec 29 | 4.40 | 4.15 | 4.64 | 11.79 |
| Dec 30 | 4.57 | 4.45 | 4.83 | 8.41 |
| Dec 31 | 4.45 | 4.29 | 4.55 | 6.04 |
| Jan 01 | 4.68 | 4.50 | 4.85 | 7.79 |
| Jan 02 | 4.87 | 4.64 | 5.06 | 8.96 |
| Jan 03 | 4.78 | 4.52 | 5.02 | 11.17 |
| Jan 04 | 4.63 | 4.49 | 4.80 | 6.78 |
| Jan 05 | 4.74 | 4.54 | 4.85 | 6.72 |
| Jan 06 | 4.41 | 4.21 | 4.59 | 9.09 |
Biofrontera Daily Price Targets
Biofrontera Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $4.11.
Positive dynamics for Biofrontera shares will prevail with possible volatility of 7.208%.
Pessimistic target level: 3.96
Optimistic target level: 4.27
Biofrontera Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $4.04.
Negative dynamics for Biofrontera shares will prevail with possible volatility of 7.365%.
Pessimistic target level: 3.91
Optimistic target level: 4.22
Biofrontera Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $3.80.
Negative dynamics for Biofrontera shares will prevail with possible volatility of 5.654%.
Pessimistic target level: 3.73
Optimistic target level: 3.95
Biofrontera Stock Forecast 12-11-2023.
Forecast target price for 12-11-2023: $3.69.
Negative dynamics for Biofrontera shares will prevail with possible volatility of 7.569%.
Pessimistic target level: 3.50
Optimistic target level: 3.78
Biofrontera Stock Forecast 12-12-2023.
Forecast target price for 12-12-2023: $3.86.
Positive dynamics for Biofrontera shares will prevail with possible volatility of 5.344%.
Pessimistic target level: 3.73
Optimistic target level: 3.95
Biofrontera Stock Forecast 12-13-2023.
Forecast target price for 12-13-2023: $3.81.
Negative dynamics for Biofrontera shares will prevail with possible volatility of 7.533%.
Pessimistic target level: 3.63
Optimistic target level: 3.93
BFRI (BFRI) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec. | 4.22 | 3.64 | 4.46 | 18.24 |
Biofrontera forecast for this year
Biofrontera Stock Prediction for Dec 2023
An uptrend is forecast for this month with an optimal target price of $4.21979. Pessimistic: $3.64. Optimistic: $4.46
Biofrontera (BFRI) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 3.92 | 3.77 | 4.33 | 13.04 |
| Mar | 3.90 | 3.47 | 4.37 | 20.69 |
| Mar | 4.03 | 3.69 | 4.58 | 19.32 |
| Apr | 4.19 | 3.83 | 4.54 | 15.60 |
| May | 4.53 | 4.19 | 5.10 | 17.74 |
| Jun | 4.69 | 4.33 | 5.12 | 15.50 |
| Jul | 4.34 | 3.99 | 4.88 | 18.25 |
| Aug | 4.19 | 3.72 | 4.69 | 20.72 |
| Sep | 3.95 | 3.68 | 4.43 | 16.84 |
| Oct | 3.87 | 3.46 | 4.20 | 17.73 |
| Nov | 3.81 | 3.56 | 4.05 | 12.02 |
| Dec | 4.13 | 3.70 | 4.42 | 16.17 |
Biofrontera (BFRI) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 4.78 | 4.26 | 5.10 | 16.54 |
| Mar | 5.01 | 4.52 | 5.40 | 16.35 |
| Mar | 5.63 | 4.99 | 6.20 | 19.59 |
| Apr | 5.65 | 5.01 | 6.29 | 20.37 |
| May | 5.78 | 5.08 | 6.03 | 15.70 |
| Jun | 5.75 | 5.19 | 6.04 | 14.05 |
| Jul | 5.47 | 4.69 | 5.89 | 20.38 |
| Aug | 5.00 | 4.52 | 5.67 | 20.30 |
| Sep | 4.67 | 4.19 | 5.09 | 17.70 |
| Oct | 4.15 | 3.87 | 4.69 | 17.53 |
| Nov | 4.88 | 4.60 | 5.27 | 12.82 |
| Dec | 5.33 | 4.77 | 5.89 | 19.07 |
Biofrontera (BFRI) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 4.89 | 4.50 | 5.54 | 18.74 |
| Mar | 4.67 | 4.02 | 5.34 | 24.70 |
| Mar | 4.35 | 3.89 | 4.83 | 19.46 |
| Apr | 3.94 | 3.62 | 4.37 | 17.19 |
| May | 3.85 | 3.44 | 4.27 | 19.63 |
| Jun | 3.71 | 3.42 | 4.22 | 19.00 |
| Jul | 3.52 | 3.27 | 3.66 | 10.56 |
| Aug | 3.23 | 2.81 | 3.65 | 22.98 |
| Sep | 3.47 | 3.19 | 3.74 | 14.73 |
| Oct | 3.81 | 3.32 | 4.27 | 22.17 |
| Nov | 4.43 | 4.09 | 4.74 | 13.62 |
| Dec | 4.95 | 4.33 | 5.34 | 18.88 |
Biofrontera (BFRI) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 4.81 | 4.58 | 5.04 | 9.27 |
| Mar | 5.17 | 4.89 | 5.76 | 15.17 |
| Mar | 4.51 | 4.18 | 5.07 | 17.48 |
| Apr | 4.51 | 4.05 | 4.96 | 18.34 |
| May | 4.37 | 4.20 | 4.55 | 7.61 |
| Jun | 4.41 | 4.00 | 4.98 | 19.76 |
| Jul | 4.26 | 4.00 | 4.69 | 14.72 |
| Aug | 4.08 | 3.50 | 4.41 | 20.65 |
| Sep | 4.06 | 3.74 | 4.33 | 13.50 |
| Oct | 4.23 | 3.64 | 4.74 | 23.13 |
| Nov | 4.15 | 3.57 | 4.49 | 20.48 |
| Dec | 4.76 | 4.46 | 5.31 | 15.98 |
Biofrontera information and performance
120 PRESIDENTIAL WAY,, SUITE 330, WOBURN, MA, US
Market capitalization of the Biofrontera Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BFRI shares in the company outstanding by the market price of one share.
EBITDA of Biofrontera is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
